Clorox (CLX) Reports Q2 Revenue About In-Line with Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Clorox (CLX) PT Lowered to $147 at BMO Capital
February 6, 2018 8:54 AM ESTBMO Capital lowered its price target on Clorox (NYSE: CLX) to $147.00 (from $150.00) while maintaining a Outperform rating.
... MoreClorox (CLX) PT Lowered to $137 at Deutsche Bank on 2Q Report; 'Challenged on the Margin... Near-Term Fundamental Pressures'
February 5, 2018 6:20 AM ESTDeutsche Bank lowered its price target on Clorox (NYSE: CLX) to $137.00 (from $158.00) while maintaining a Hold rating, following the company's second quarter 2018 earnings report.
Analyst Steve Powers notes a cautious outlook on the shares, as CLX reported second quarter revenue results below consensus... More
Buy Clorox (CLX) on Today's Weakness - BMO
February 2, 2018 11:10 AM ESTBMO Capital analyst Shannon Coyne is telling clients to buy Clorox (NYSE: CLX) on today's weakness.
Coyne commented, "CLX reported 2Q/18 adj. EPS of $1.77, beating Consensus/BMO of $1.23/$1.26, though quality was low ($0.61 benefit from a lower effective tax rate) and revenues light. Management raised... More
